Evogene Ltd. (EVGN)

Evogene Revenue

Evogene had revenue of $1.80M in the quarter ending September 30, 2024, a decrease of -52.32%. This brings the company's revenue in the last twelve months to $7.48M, up 30.69% year-over-year. In the year 2023, Evogene had annual revenue of $5.64M with 236.72% growth.

• Revenue (ttm): $7.48M
• Revenue Growth: +30.69%
• P/S Ratio: n/a
• Revenue / Employee: $52,662
• Employees: 142
• Market Cap: 8.78M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.64M	3.97M	236.72%
Dec 31, 2022	1.68M	745.00K	80.11%
Dec 31, 2021	930.00K	-110.00K	-10.58%
Dec 31, 2020	1.04M	287.00K	38.11%
Dec 31, 2019	753.00K	-994.00K	-56.90%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.